Visualant to Present at 7th Annual LD MICRO Conference on December 2, 2014 & Benchmark's Micro Cap Discovery Conference Decem...
26 Novembre 2014 - 3:30PM
Business Wire
Visualant, Inc. (OTCQB: VSUL), a leading provider of disruptive
light-based technologies through its ChormaID™ technology,
announced today that the Company will participate in two upcoming
investor conferences. The conference details are as follows:
- Visualant President and CEO Ron
Erickson is scheduled to present at the LD Micro Conference on
Tuesday, December 2nd at 7:30 a.m. PST in Track 3, with one-on-one
meetings held throughout the day. He will discuss the company's new
strategic partnership with Intellectual Ventures, the global leader
in the business of invention, to advance the commercialization of
Visualant's patented ChormaID™ technology through product
applications and IP development. Visualant has approximately 30
patents filed to date and 7 have been issued.Management's
presentation will be webcast live via
http://wsw.com/webcast/ldmicro5/VSUL, and available for replay
following the conference in the investors section of Visualant's
website at www.visualant.net. For additional information about the
LD MICRO Conference, please visit www.ldmicro.com or email
bzuckerman@genesisselect.com for 1 on 1 meeting slots.
- Benchmark's Micro Cap Discovery
Conference to be held on Thursday, December 11, 2014 at the Palmer
House Hilton in Chicago, Illinois. Mr. Erickson will participate in
one-on-one investor meetings from 8:00 am – 3:30 pm CST.For
additional information about the Benchmark Micro Cap Discovery
Conference, contact your institutional salesperson or visit
http://www.benchmarkcompany.com/conference.php
About Visualant, Inc.
Visualant™ is a public company whose shares trade under the
stock symbol "VSUL." The Visualant Spectral Pattern Matching™ (SPM)
technology directs structured light onto a substance or material,
through a liquid or gas, or off a surface, to capture a unique
ChormaID™. A ChormaID can be used to identify, detect, or diagnosis
markers invisible to the human eye. ChormaID scanner modules can be
integrated into a variety of mobile or fixed-mount form factors.
The patented, award-winning technology is disruptive, making it
possible to effectively conduct analyses in the field that could
only previously be performed by large and expensive lab-based
tests. For more information on Visualant, visit the company's new
website at www.visualant.net.
About LD Micro
LD Micro is an investment newsletter firm that focuses on
finding undervalued companies in the micro-cap space. Since 2002,
the firm has published reports on select companies throughout the
year. The firm also hosts the LD Micro Invitational. It is a
non-registered investment advisor. For more information, please
contact 408-457-1042 or visit www.ldmicro.com.
About The Benchmark Company
Headquartered in New York with 11 offices coast to coast, The
Benchmark Company, LLC is an institutional brokerage firm that
provides Research, Sales, Trading and Investment Banking services
to public companies and their investors.
Investor Relations:Genesis SelectBudd Zuckerman,
303-415-0200bzuckerman@genesisselect.comorVisualant Press
Contacts:Hal BringmanDesk +1 (206) 299-0622 ext 801Mobile +1 (310)
210-8011hal@nvpr.comSkype halbringman
Know Labs (PK) (USOTC:KNWN)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Know Labs (PK) (USOTC:KNWN)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025
Real-Time news about Know Labs Inc (PK) (OTCMarkets): 0 recent articles
Plus d'articles sur Visualant, Inc. (QB)